SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001415889-16-005504
Filing Date
2016-04-12
Accepted
2016-04-13 07:58:01
Documents
6
Period of Report
2016-05-26
Effectiveness Date
2016-04-12

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE SCHEDULE 14A echodef14a_may2016.htm DEF 14A 436213
2 echodef14a_may20161.jpg GRAPHIC 1327
3 echodef14a_may20162.jpg GRAPHIC 1160
4 echodef14a_may20163.jpg GRAPHIC 1088
5 echodef14a_may20164.jpg GRAPHIC 1482
6 echodef14a_may20165.jpg GRAPHIC 11083
  Complete submission text file 0001415889-16-005504.txt   460504
Mailing Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830
Business Address 99 WOOD AVENUE SOUTH SUITE 302 ISELIN NJ 08830 732-549-0919
Echo Therapeutics, Inc. (Filer) CIK: 0001031927 (see all company filings)

IRS No.: 411649949 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35218 | Film No.: 161568383
SIC: 3845 Electromedical & Electrotherapeutic Apparatus